Tor D Tosteson, ScD
Professor of Biomedical Data Science
Professor of The Dartmouth Institute
Professor of Community and Family Medicine
Director, Division of Biostatistics, Department of Biomedical Data Science
Biomedical Data Science
The Dartmouth Institute
Community and Family Medicine
Biostatistics, Harvard University, SCD
Biostatistics, Harvard University, MS
Economics, University of North Carolina - Chapel Hill, BA
Norris Cotton Cancer Center
The Dartmouth Institute for Health Policy and Clinical Practice
Geisel School of Medicine at Dartmouth
One Medical Center Drive
Lebanon NH 03756
My current research interests revolve around challenging methodological and statistical problems in biomedical data science. I collaborate extensively in the areas of cancer and musculoskeletal disease involving clinical, translational and outcomes research. I develop related statistical methodology in the areas of covariate measurement error for nonlinear regression models, clinical trials, instrumental variables,joint modeling of survival and longitudinal patient outcomes, and randomization in learning health systems.
T32 CA134286-11 Training Program for Quantitative Population Sciences in Cancer (MPI)
NCI P30 CA023108-41 Biostatistics and Bioinformatics (BBSR) (Subaward PI)
T32 LM012204-05 Predoctoral Training in Quantitative Biomedical Sciences at Dartmouth (PI)
QBS Fundamentals of Biostatistics I & II; QBS Statistical Consulting
I am an active mentor for pre and post docs and junior faculty and lead 2 NIH training grants.
Prior to coming to Dartmouth, I spent 5 years on the faculties of Harvard Medical School at the Channing Laboratory, and Harvard School of Public Health in the Department of Biostatistics. I was elected as a Fellow of the American Statistical Association in 2014.
Evaluating Physician Emotion Regulation in Serious Illness Conversations Using Multimodal Assessment.
Association of Life Expectancy With Surveillance Colonoscopy Findings and Follow-up Recommendations in Older Adults.
Preventing metastatic recurrence in low-risk ER/PR + breast cancer patients-a retrospective clinical study exploring the evolving challenge of persistence with adjuvant endocrine therapy.
A phase I trial of BNC105P and ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia.
Sensitizing brain metastases to stereotactic radiosurgery using hyperbaric oxygen: A proof-of-principle study.
Adoption of Telemedicine in a Rural US Cancer Center Amid the COVID-19 Pandemic: Qualitative Study.
Factors Influencing Telemedicine Use at a Northern New England Cancer Center During the COVID-19 Pandemic.
Effectiveness of a Self-Management Program to Improve Cognition and Quality of Life in Epilepsy: A Pragmatic, Randomized, Multicenter Trial.
Colonoscopy utilization and outcomes in older adults: Data from the New Hampshire Colonoscopy Registry.
Guidance for biostatisticians on their essential contributions to clinical and translational research protocol review.